Pharma News
-
Pharma giants to refocus on novel antibiotics market with $1B venture fund
Pharma | News | 0 Comment | 09 Jul, 2020
On 9 July 2020, a group of pharmaceutical companies along with Pfizer, Merck (KGaA and the American Merck), Eli Lilly, N...Read more
-
Vetter further expands its Development Service with new site in Austria
Pharma | News | 0 Comment | 08 Jul, 2020
CDMO addressing growing customer demand Investment in additional clinical f...Read more
-
Piramal Pharma acquires Solid Oral Dosage Drug Product Facility in Pennsylvania
Pharma | News | 0 Comment | 08 Jul, 2020
Piramal Enterprises Limited’s (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Or...Read more
-
FDA approves Roche’s Phesgo for HER2-positive breast cancer
Pharma | News | 0 Comment | 08 Jul, 2020
US Food and Drug Administration (FDA) has approved Roche's Phesgo™, a fixed-dose combination of Perjeta® ...Read more
-
Hong Kong approves Eisai's anti-insomnia drug Dayvigo
Pharma | News | 4 Comment | 10 Jul, 2020
Japanese firm Eisai Co., Ltd. has announced that the new drug application for approval of its in-house-discovered and de...Read more
-
Lipidor AB (publ) announces Stina Linge as new CEO of subsidiary Emollivet AB
Pharma | News | 0 Comment | 07 Jul, 2020
Lipidor AB, on 7 July 2020, announced that the subsidiary Emollivet AB ("Emollivet") has recruited Stina Linge as CEO. S...Read more
-
Daewoong Pharma expands influence across Asia
Pharma | News | 0 Comment | 08 Jul, 2020
Korea's Daewoong Pharmaceutical’s original botulinum toxin product Nabota is stepping up to expand its influence a...Read more
-
Japan launches Fine Granule Formulation of Anti-epileptic Drug Fycompa
Pharma | News | 0 Comment | 06 Jul, 2020
Eisai Co., Ltd. announced on 6 July 2020 that it has launched a new fine granule formulation of its in-house-discov...Read more
-
The key to tackling drug development complexity: Collaboration
Pharma | News | 0 Comment | 06 Jul, 2020
Vetter and Rentschler Biopharma, two globally operating Contract Development and Manufacturing Organizations (CDMOs...Read more
-
Eisai launches anti-insomnia drug in Japan
Pharma | News | 0 Comment | 08 Jul, 2020
Japanese firm Eisai Co., Ltd. announced that it has launched its in-house-discovered and developed orexin receptor antag...Read more
-
Dr Reddy’s leads COVID-19 treatment with Favipiravir and Remdesivir in portfolio
Pharma | Analysis | 0 Comment | 06 Jul, 2020
Indian pharmaceutical giant Dr. Reddy’s Laboratories (Dr Reddy’s) has signed a tripartite agreement with Tok...Read more
-
Fujifilm, Dr. Reddy and Global Response Aid to co-develop anti COVID-19 drug
Pharma | News | 0 Comment | 03 Jul, 2020
FUJIFILM Corporation partners with Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company headquartered in...Read more
-
CF PharmTech pushes commercialization of inhalation products
Pharma | News | 0 Comment | 07 Jul, 2020
China based CF PharmTech, Inc. announced that it has raised US $50M in Series F financing following its US $90...Read more
-
Daiichi Sankyo in discussion with AZ for COVID-19 vaccine supply
Pharma | News | 0 Comment | 02 Jul, 2020
Japan based Daiichi Sankyo Company, Limited has announced its agreement to proceed with discussions with AstraZeneca for...Read more
-
Korea approves Equfina for Parkinson's treatment
Pharma | News | 1 Comment | 01 Jul, 2020
Japanese firm Eisai Co., Ltd. has announced that Eisai Korea Inc., Eisai’s subsidiary in South Korea, has received...Read more
-
Merck’s KEYTRUDA (pembrolizumab) approved in China for ESCC Tumors
Pharma | News | 0 Comment | 23 Jun, 2020
Merck, known as MSD outside the United States and Canada, on 22 June 2020 announced that KEYTRUDA, Merck&rsquo...Read more
-
Biocon, DKSH to commercialize 7 generic formulations in SEA markets
Pharma | News | 0 Comment | 23 Jun, 2020
India based Biocon Ltd, an innovation-led global biopharmaceutical company, and Switzerland headquartered DKSH, a l...Read more
-
Alphamab, Sanofi collaborate for breast cancer research
Pharma | News | 0 Comment | 18 Jun, 2020
China based Alphamab Oncology, a clinical stage biopharmaceutical company focusing on innovative biologics medicine...Read more
